KATY TROTTER: Open Payments
NPI 1386969467 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,194 in 56 payments from 16 companies in 2025. Trend: 2023 $2,418 · 2024 $1,080 · 2025 $1,194
Food & beverage: $1,127Education: $67
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $380 |
| Janssen Biotech, Inc. | 7 | $186 |
| UCB, Inc. | 8 | $146 |
| Lilly USA, LLC | 4 | $90 |
| Amgen Inc. | 3 | $63 |
| ABBVIE INC. | 3 | $60 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Incyte Corporation | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $36 |
Products named: CIBINQO, TREMFYA, OTEZLA, Bimzelx, TALTZ, OPZELURA, DUPIXENT, ILUMYA.
Industry payments across OK — which companies pay providers there.
